Consistent with our findings, previous studies also observed that TAK165 significantly inhibited tumor growth compared with Herceptin in urological cancers with weak HER2 expression9, and TAK165-inhibted cell proliferation might be regulated by the suppression of ERK phosphorylation instead of HER2 inhibition29. The gene discussed is ERBB2; the disease is neoplasm.